ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 181 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $382,000 | -62.9% | 6,183 | -63.9% | 0.02% | -63.5% |
| Q3 2019 | $1,030,000 | +270.5% | 17,147 | +397.6% | 0.05% | +372.7% |
| Q1 2018 | $278,000 | -41.7% | 3,446 | -77.8% | 0.01% | -50.0% |
| Q1 2017 | $477,000 | +78.0% | 15,500 | +93.8% | 0.02% | +37.5% |
| Q4 2016 | $268,000 | -73.9% | 8,000 | -77.1% | 0.02% | -65.2% |
| Q1 2016 | $1,025,000 | +198.8% | 34,915 | +235.2% | 0.05% | +187.5% |
| Q4 2015 | $343,000 | -87.4% | 10,415 | -88.3% | 0.02% | -83.0% |
| Q1 2015 | $2,728,000 | +192.7% | 89,103 | +385.7% | 0.09% | +168.6% |
| Q4 2014 | $932,000 | – | 18,347 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,546,097 | $66,590,000 | 9.91% |
| RA Capital Management | 1,539,586 | $66,310,000 | 6.70% |
| SENZAR ASSET MANAGEMENT, LLC | 255,128 | $10,988,000 | 4.20% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 158,315 | $6,819,000 | 1.56% |
| Sarissa Capital Management LP | 105,000 | $4,522,000 | 1.54% |
| Ghost Tree Capital, LLC | 50,000 | $2,154,000 | 1.52% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 118,445 | $5,102,000 | 0.90% |
| WALL STREET ASSOCIATES | 219,200 | $9,441,000 | 0.81% |
| Granite Point Capital Management, L.P. | 25,000 | $1,077,000 | 0.74% |
| BAILARD, INC. | 91,500 | $3,941,000 | 0.61% |